A government report shows how dozens of drugs that received a special “accelerated” approval have no proof of actual clinical benefit to patients. Action Alert! Taxpayers are spending billions on drugs that have little or no data to support their efficacy. This is the bombshell finding of a report from the Office of Inspector General (OIG) on the failings of the FDA’s accelerated drug approval program. Read more.